ATA-Mg+
Natural health product licensed in Canada
- Other names
- ATA-Mg with Saffron, Advanced Mood Balance, Advanced Mood Manager, Mag Mood, Magnesium Saffron Balance, Mood Mag, Ortho Mag+
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80137955
- Status
- Active licence
- Licence date
- 21 January 2025
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Acétyl taurate de magnésium | 25 mg | 50,000 µg |
| Crocus sativus Source : Stigmates Extract : Matériel brut sec Extraction ratio : 3:1 Dry plant equivalent : 42 mg Potency : 0.03 % 2,6,6-Trimethylcyclohexa-1,3-diene-1-carbaldehyde | 14 mg | Not calculated |
| Crocus sativus Source : Stigmates Potency : 3.48 % Crocin | Not specified | Not calculated |
Non-medicinal ingredients
Stéaryl fumarate de sodium, Poudre de racine de carotte, Dioxyde de silicium, Maltodextrine, Cellulose microcristalline, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Affron® helps to relieve restlessness and nervousness (calmative). Supports positive effects on symptoms of perceived stress such as, fatigue, weariness and irritability. Helps to reduce the symptoms of perceived stress, such as fatigue, weariness, and irritability. Helps to improve restorative sleep and sleep quality in individuals experiencing sleeplessness. Helps to support/maintain (healthy) mood balance. Supports the management of symptoms associated with perimenopause. Clinically proven to help improve sleep quality in 4 weeks. Helps to support healthy mood balance during perimenopause. Clinically shown to help relieve symptoms associated with perimenopause. Helps to support healthy mood balance after awakening. Nighttime sleep aid. Helps in the development and maintenance of bones/(and) teeth. Helps to maintain/support heart muscle function. Source of/Provides (an) electrolyte(s). Source of/Provides (an) electrolyte(s) for the maintenance of good health. Contributes to electrolyte balance. Helps in energy metabolism/(and) tissue formation . A factor in normal nerve function. A factor in normal brain function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80137955
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.